Technology platform
Cebiotex’s technology platform is built on patented biomedical nanofiber membranes designed for local, targeted drug delivery in surgical indications.
Our core technology enables the creation of biocompatible and biodegradable nanofiber membranes that can be loaded with therapeutic agents for sustained, localized release directly at the surgical site. This approach minimizes systemic toxicity and side effects commonly associated with systemic drug administration, while maximizing therapeutic impact where it is most needed.
Patented product and technology: Two patent families in Europe , US, China and Japan.
Cebiotex is developing a pipeline of nanofiber-based drug delivery candidates to broaden treatment options across diverse surgical indications. Our pipepline includes ongoing Phase II studies in pancreatic cancer and pediatric tumors, with additional nanofiber-based drug delivery candidates under development to expand treatment options across diverse surgical indications.
Select a button and click one of the circular hotspots to explore our potential applications.
GLIOBLASTOMA
PANCREATIC CANCER
SOFT TISSUE SARCOMA
FIBROLAMELLAR
HEPATOCELLULAR SARCOMA
NEUROBLASTOMA
EXTRACRANIAL MALIGNANT
RHABDOID TUMOUR
WILMS TUMOUR
DESMOPLASTIC SMALL
ROUND CELL TUMOUR
GERM CELL TUMOUR
SYNOVIAL SARCOMA
DIFFUSE ABDOMINAL
HEMORRHAGE
DIFFUSE ABDOMINAL
HEMORRHAGE
OSTEOMYELITIS
OSTEOMYELITIS